Quest Diagnostics (DGX) Other financing activities (2009 - 2026)

Quest Diagnostics has disclosed Other financing activities across 18 years of filings, most recently posting -$25.0 million for Q2 2026.

• In Q2 2026, Other financing activities fell 327.27% year-over-year to -$25.0 million; the TTM figure through Jun 2026 stood at $20.0 million (down 67.74% YoY), while the FY2025 annual figure was $79.0 million, up 8.22% from the prior year.
• Other financing activities came in at -$25.0 million for Q2 2026 at Quest Diagnostics, up from -$84.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $140.0 million in Q4 2025 to a low of -$84.0 million in Q1 2026.
• Average Other financing activities over 5 years is $13.2 million, with a median of $13.5 million recorded in 2022.
• Year-over-year, Other financing activities soared 600.0% in 2024 and sank 327.27% in 2026.
• Over 5 years, Other financing activities stood at $27.0 million in 2022, then plunged by 55.56% to $12.0 million in 2023, then surged by 75.0% to $21.0 million in 2024, then soared by 566.67% to $140.0 million in 2025, then tumbled by 117.86% to -$25.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were -$25.0 million in Q2 2026, -$84.0 million in Q1 2026, and $140.0 million in Q4 2025.